论文信息 - A case of compensated liver cirrhosis with hepatitis C virus of genotype 1b and high viral load in whom sustained virological response was achieved by 2-year administration of very low-dose recombinant interferon alpha-2b.

A case of compensated liver cirrhosis with hepatitis C virus of genotype 1b and high viral load in whom sustained virological response was achieved by 2-year administration of very low-dose recombinant interferon alpha-2b.

Approximately two million people are infected with hepatitis C virus (HCV) and it is a primary cause of hepatocellular carcinoma (HCC) in Japan [1]. Pegylated interferon (IFN) with ribavirin treatment is the standard therapy for chronic HCV infection nowadays, and the treatment achieves a sustained

R. Ueda | A. Nakamura | H. Kato | Makoto Nakamura

[1] Yoshiyuki Suzuki,et al. Predictive factors of virological non‐response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load , 2006, Journal of medical virology.

[2] J. Tanaka,et al. National Prevention of Hepatocellular Carcinoma in Japan Based on Epidemiology of Hepatitis C Virus Infection in the General Population , 2005, Intervirology.

[3] N. Terrault,et al. Hepatitis C and hepatocellular carcinoma , 2001, Current treatment options in oncology.

[4] J. Schmidt,et al. Hepatitis C virus dynamics in vivo: Effect of ribavirin and interferon alfa on viral turnover , 1998, Hepatology.

[5] N Enomoto,et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.

[6] A. Bisceglie,et al. Hepatitis C and Hepatocellular Carcinoma , 1995, Seminars in liver disease.